Authors: | Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; Dandapani, S.; Drullinsky, P.; Friedberg, J. W.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Hoppe, R. T.; Horwitz, S. M.; Matasar, M. J.; Miller, S. T.; Moskowitz, A. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Schoder, H.; Straus, D. J.; Yang, J. C.; Younes, A.; Zelenetz, A. D.; Zhang, Z. G.; Yahalom, J.; Moskowitz, C. H. |
Abstract Title: | A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma |
Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
Journal Title: | Blood |
Volume: | 130 |
Issue: | Suppl. 1 |
Meeting Dates: | 2017 Dec 9-12 |
Meeting Location: | Atlanta, GA |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Date Published: | 2017-12-07 |
Language: | English |
ACCESSION: | WOS:000432419401381 |
PROVIDER: | wos |
DOI: | 10.1182/blood.V130.Suppl_1.734.734 |
Notes: | Meeting Abstract: 734 -- Source: Wos |